Resveratrol Ameliorates Diabetes-Induced Cardiac Dysfunction Through AT1R-ERK/p38 MAPK Signaling Pathway. (Q54282810)

27 May 2018

title

Resveratrol Ameliorates Diabetes-Induced Cardiac Dysfunction Through AT1R-ERK/p38 MAPK Signaling Pathway. (English)

1 reference

27 May 2018

author name string

Yonglin Gao

1

1 reference

27 May 2018

Le Kang

2

1 reference

27 May 2018

Chunmei Li

3

1 reference

27 May 2018

Xiaoyan Wang

4

1 reference

27 May 2018

Chengfeng Sun

5

1 reference

27 May 2018

Qingzhong Li

6

1 reference

27 May 2018

Ruihua Liu

7

1 reference

27 May 2018

Jianping Wang

8

1 reference

27 May 2018

publication date

1 April 2016

1 reference

27 May 2018

Cardiovascular Toxicology

published in

1 reference

27 May 2018

volume

16

1 reference

27 May 2018

issue

2

1 reference

27 May 2018

page(s)

130-137

1 reference

27 May 2018

https://scigraph.springernature.com/pub.10.1007/s12012-015-9321-3

exact match

0 references

cites work

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

1 reference

https://api.crossref.org/works/10.1007%2FS12012-015-9321-3

Heart failure: the frequent, forgotten, and often fatal complication of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-015-9321-3

Diabetic cardiomyopathy revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-015-9321-3

Angiotensin-(1-7) activates a tyrosine phosphatase and inhibits glucose-induced signalling in proximal tubular cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-015-9321-3

Dietary polyphenols: focus on resveratrol, a promising agent in the prevention of cardiovascular diseases and control of glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-015-9321-3

Effect of resveratrol on glucose control and insulin sensitivity: a meta-analysis of 11 randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-015-9321-3

Inhibition of cardiac fibroblast proliferation and myofibroblast differentiation by resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-015-9321-3

Diabetes increases formation of advanced glycation end products on Sarco(endo)plasmic reticulum Ca2+-ATPase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-015-9321-3

Resveratrol inhibits high glucose-induced PI3K/Akt/ERK-dependent interleukin-17 expression in primary mouse cardiac fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-015-9321-3

Reduced adipose tissue inflammation represents an intermediate cardiometabolic phenotype in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-015-9321-3

Antihyperglycemic effects of short term resveratrol supplementation in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-015-9321-3

Medicinal chemistry of drugs used in diabetic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-015-9321-3

NLRP3 gene silencing ameliorates diabetic cardiomyopathy in a type 2 diabetes rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-015-9321-3

Direct renin inhibition prevents cardiac dysfunction in a diabetic mouse model: comparison with an angiotensin receptor antagonist and angiotensin-converting enzyme inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-015-9321-3

Angiotensin type 1a receptor-deficient mice develop diabetes-induced cardiac dysfunction, which is prevented by renin-angiotensin system inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-015-9321-3

TGF-beta1 and angiotensin networking in cardiac remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-015-9321-3

The stress-activated protein kinase pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-015-9321-3

Modulation of AT-1R/AMPK-MAPK cascade plays crucial role for the pathogenesis of diabetic cardiomyopathy in transgenic type 2 diabetic (Spontaneous Diabetic Torii) rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-015-9321-3

Effects of prediabetes and diabetes on left ventricular and coronary microvascular functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-015-9321-3

SIRT1, a longevity gene, downregulates angiotensin II type 1 receptor expression in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-015-9321-3

Resveratrol induces mitochondrial biogenesis and ameliorates Ang II-induced cardiac remodeling in transgenic rats harboring human renin and angiotensinogen genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-015-9321-3

One-Year Consumption of a Grape Nutraceutical Containing Resveratrol Improves the Inflammatory and Fibrinolytic Status of Patients in Primary Prevention of Cardiovascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12012-015-9321-3

10.1007/S12012-015-9321-3

21 January 2018

Identifiers

DOI

1 reference

27 May 2018

PubMed ID

25800751

1 reference

27 May 2018